NVC - Neovasc Stock Price, News & Analysis

C$1.78 0.04 (2.30 %)
(As of 11/22/2017 01:09 PM ET)
Previous CloseC$1.74
Today's RangeC$1.76 - C$1.82
52-Week RangeC$0.49 - C$6.07
Volume46,869 shs
Average Volume111,876 shs
Market CapitalizationC$86.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

About Neovasc (TSE:NVC)

Neovasc logoNeovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: N/A
  • Symbol: TSE:NVC
  • CUSIP: N/A
  • Web: www.neovasc.com
Profitability:
  • Trailing EPS: C($0.08)
  • Net Margins: -409.25%
  • Return on Assets: -23.96%
Misc:
  • Outstanding Shares: 78,683,000
 

Frequently Asked Questions for Neovasc (TSE:NVC)

What is Neovasc's stock symbol?

Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."

When will Neovasc make its next earnings announcement?

Neovasc is scheduled to release their next quarterly earnings announcement on Thursday, March, 22nd 2018. View Earnings Estimates for Neovasc.

Who are some of Neovasc's key competitors?

Who are Neovasc's key executives?

Neovasc's management team includes the folowing people:

  • Paul L. Geyer, Independent Chairman of the Board
  • Alexei J. Marko, Chief Executive Officer, Director
  • Christopher Clark, Chief Financial Officer, Corporate Secretary
  • Brian McPherson, Chief Operating Officer
  • Vicki Lee Bebeau, Vice President - Clinical Affairs
  • Randy Lane, Vice President - Research & Development
  • Jane H. Hsiao Ph.D., Independent Director (Age 69)
  • Douglas Glen Janzen, Independent Director
  • William O'Neill, Independent Director (Age 61)
  • Steven D. Rubin Esq. J.D., Independent Director (Age 56)

How do I buy Neovasc stock?

Shares of Neovasc and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Neovasc's stock price today?

One share of Neovasc stock can currently be purchased for approximately C$1.78.

How big of a company is Neovasc?

Neovasc has a market capitalization of C$86.77 million.

How can I contact Neovasc?

Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.


MarketBeat Community Rating for Neovasc (NVC)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Neovasc (TSE:NVC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Neovasc (TSE:NVC)

Price Target History for Neovasc (TSE:NVC)

Analysts' Ratings History for Neovasc (TSE:NVC)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Neovasc (TSE:NVC)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Neovasc (TSE:NVC)
2017 EPS Consensus Estimate: ($0.06)
2018 EPS Consensus Estimate: $0.00
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.02)($0.02)($0.02)
Q3 20171($0.02)($0.02)($0.02)
Q4 20171($0.02)($0.02)($0.02)
Q1 20181$0.00$0.00$0.00
Q2 20181$0.00$0.00$0.00
Q3 20181$0.00$0.00$0.00
Q4 20181$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Neovasc (TSE:NVC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neovasc (TSE NVC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Neovasc (TSE NVC)

Source:
DateHeadline
Research Analysts Issue Forecasts for Neovasc Incs FY2017 Earnings (NVC)Research Analysts Issue Forecasts for Neovasc Inc's FY2017 Earnings (NVC)
www.americanbankingnews.com - November 17 at 7:44 PM
Neovasc Inc (NVC) Scheduled to Post Earnings on TuesdayNeovasc Inc (NVC) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - November 13 at 8:54 AM
Will Neovasc (NVCN) Continue to Surge Higher?Will Neovasc (NVCN) Continue to Surge Higher?
finance.yahoo.com - October 5 at 12:48 PM
athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1
finance.yahoo.com - October 5 at 12:48 PM
Allscripts (MDRX) Beats on Q1 Earnings, Revenues In LineAllscripts (MDRX) Beats on Q1 Earnings, Revenues In Line
finance.yahoo.com - October 5 at 12:48 PM
Neovasc reports 1Q lossNeovasc reports 1Q loss
finance.yahoo.com - October 5 at 12:48 PM
FY2020 EPS Estimates for Neovasc Inc. Decreased by Leerink Swann (NVC)FY2020 EPS Estimates for Neovasc Inc. Decreased by Leerink Swann (NVC)
www.americanbankingnews.com - August 14 at 10:06 AM
Neovasc Inc. (TSE:NVC) Set to Announce Earnings on ThursdayNeovasc Inc. (TSE:NVC) Set to Announce Earnings on Thursday
www.americanbankingnews.com - August 4 at 3:32 PM

Social Media

Financials

Financials are not available for this stock.

Chart

Neovasc (TSE NVC) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.